Balyasny Asset Management’s ImmunityBio IBRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$797K	Buy	103,871 +52,231	+101%	+$358K	﹤0.01%	2170
2025 Q4	$102K	Buy	51,640 +33,914	+191%	+$76.8K	﹤0.01%	2954
2025 Q3	$43.6K	Buy	+17,726	New	+$45.6K	﹤0.01%	2827
2025 Q2	–	Sell	-56,165	Closed	-$169K	–	3092
2025 Q1	$169K	Buy	+56,165	New	+$170K	﹤0.01%	2620
2024 Q4	–	Sell	-65,811	Closed	-$245K	–	3000
2024 Q3	$245K	Sell	65,811 -141,385	-68%	-$654K	﹤0.01%	2508
2024 Q2	$1.31M	Buy	+207,196	New	+$1.37M	﹤0.01%	1692
2023 Q3	–	Sell	-193,285	Closed	-$537K	–	2487
2023 Q2	$537K	Buy	193,285 +121,019	+167%	+$342K	﹤0.01%	1834
2023 Q1	$132K	Sell	72,266 -824,695	-92%	-$2.56M	﹤0.01%	2290
2022 Q4	$4.55M	Buy	896,961 +849,054	+1,772%	+$4.66M	0.02%	1073
2022 Q3	$238K	Sell	47,907 -17,038	-26%	-$77.6K	﹤0.01%	2266
2022 Q2	$242K	Buy	+64,945	New	+$261K	﹤0.01%	2158
2018 Q2	–	Sell	-11,189	Closed	-$44K	–	1952
2018 Q1	$44K	Buy	+11,189	New	+$49.1K	﹤0.01%	1864
2017 Q3	–	Sell	-50,000	Closed	-$380K	–	1985
2017 Q2	$380K	Buy	+50,000	New	+$216K	﹤0.01%	1268